PRESS RELEASE
News
-
LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
-
GLG Life Tech Corporation Reports 2026 First Quarter Financial Results
-
Molten Metals Completes Airborne Geophysical Survey at Texas Project
-
Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
-
Water Ways Announces Corporate Updates
-
Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
-
Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
-
Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
-
Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
-
Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
-
PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
-
Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
-
Disclosure of transactions in own shares from May 18 to May 22, 2026
-
Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
-
Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026